Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Neoplasms × Physical Conditioning, Human × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Breast Neoplasms 2 Rectal Neoplasms 1 Motor Activity 1 Lung Neoplasms 1 Hodgkin Disease 1 Digestive System Neoplasms 1 Cognitive Dysfunction 1 Cardiovascular Diseases 1 Brain Neoplasms 1

Interventions

Carboplatin 288 Cisplatin 211 Radiotherapy 186 Paclitaxel 173 Pemetrexed 158 Docetaxel 147 Gemcitabine 136 pembrolizumab 124 Erlotinib Hydrochloride 93 Magnetic Resonance Spectroscopy 90 Etoposide 85 Bevacizumab 77 Specimen Handling 72 durvalumab 65 Radiosurgery 64 Nivolumab 64 Vinorelbine 50 Drug Therapy 49 Blood Specimen Collection 48 osimertinib 47 Gefitinib 42 Surveys and Questionnaires 38 atezolizumab 37 Biopsy 37 Irinotecan 36 Topotecan 35 Radiation 35 Cyclophosphamide 34 Standard of Care 33 Surgical Procedures, Operative 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01748981 2019-02-12

FALC

Oslo University Hospital

Phase NA Completed

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡